FINAL BILL REPORT
HB 2567
C 188 L 06
Synopsis as Enacted
Brief Description: Providing provisions for methamphetamine precursors.
Sponsors: By Representatives Wallace, Ericks, Morrell, Kilmer, Lovick, Campbell, Green, Lantz, Springer and Moeller.
House Committee on Criminal Justice & Corrections
Senate Committee on Judiciary
Background:
Precursor drugs are substances that can be used to manufacture controlled substances. For
example, anhydrous ammonia, ephedrine, pseudoephedrine, and phenylpropanolamine are
common precursor items that are often used to illegally manufacture methamphetamine.
Methamphetamine is a highly addictive substance that affects the central nervous system.
In 2001, legislation was enacted that placed restrictions on the sale and distribution of
ephedrine, pseudoephedrine, or phenylpropanolamine. The legislation instituted a number of
measures including: providing reporting and record keeping requirements for the sale of
these precursor substances; restricting the retail sale of the precursor substances; and limiting
the quantity that a person may possess.
Iodine is another precursor drug that can be used to manufacture methamphetamine. Iodine
is used legally for a variety of commercial and medical purposes. It is widely available and
can be used legitimately as a:
Iodine crystals may be purchased from a variety of businesses. Crystals typically are
available for sale at chemical supply stores, feed and tack stores, and veterinary clinics and
suppliers. Iodine also is widely available on the Internet.
Iodine is also frequently used illegally to produce high quality methamphetamine.
Methamphetamine producers use iodine crystals to produce hydriodic acid, the preferred
reagent in the ephedrine and pseudoephedrine reduction method of methamphetamine
production.
Methylsulfonylmethane (also known as MSM) is commonly used as a nutritional supplement
for horses and humans. Methamphetamine produced in Mexico and southwestern states is
commonly cut with MSM -- a white powder with a low melting point. It is highly soluble
and readily mixes with most substances without leaving a residue, making it a suitable
cutting agent for methamphetamine.
A gross misdemeanor offense is punishable by imprisonment of not more than one year in
jail, or by a fine of not more than $5,000, or both. A misdemeanor offense is punishable by
imprisonment in the county jail for a maximum term of not more than 90 days, or by a fine of
not more than $1,000, or both.
Summary:
It is a gross misdemeanor offense to knowingly purchase in a 30-day period or possess any
quantity of iodine in its elemental form, an iodine matrix, or more than two pounds of
methylsulfonylmethane (MSM).
The penalties do not apply to the following individuals:
The Washington State Patrol must develop a form to be used in recording transactions
involving iodine in its elemental form, an iodine matrix, or MSM. A person who purchases
any quantity of iodine in its elemental form, an iodine matrix, or any quantity of MSM must
present an identification card or driver's license before purchasing the item. A person who
sells or otherwise transfers any quantity of iodine or MSM to an authorized person must
record each sale or transfer. The record must be retained by the person for at least three
years. Any law enforcement agency may request access to the records. Failure to make or
retain a required record is a misdemeanor offense. Failure to comply with a request for
access to records is a misdemeanor offense.
"Iodine matrix" is defined as iodine at a concentration greater than 2 percent by weight in a
matrix or solution. "Matrix" means something, as a substance, in which something else
originates, develops, or is contained. "Methylsulfonylmethane" or MSM means MSM in its
powder form only, and does not include products containing MSM in other forms such as
liquids, tablets, capsules not containing MSM in pure powder form, ointments, creams,
cosmetics, foods, and beverages.
Votes on Final Passage:
House 92 3
Senate 46 0 (Senate amended)
House 96 1 (House concurred)
Effective: June 7, 2006